Skip to content
Home/Companies/Biotech/EpiBone
EpiBone

EpiBone

Biotech·United States·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns EpiBone?

EpiBone is an American Biotech company, currently owned by EMV Capital since 2020.

Hand-verified · updated 2026-07-08

Open JSON · CC-BY
EMV Capital
Investor
EMV Capital
EMV Capital Evergreen Fund · 2012 · VC

Key facts

HQUnited States
SectorBiotech
StatusActive
Websitewww.epibone.com

More from EMV Capital Evergreen Fund

Other portfolio companies in the same fund.

Dogtooth Technologies
Active
TMTUK· 2026
AMR Bio
AMR Bio
Active
BiotechUK· 2025
Dname-iT
Active
SoftwareUK· 2023
DeepTech Recycling
DeepTech Recycling
Active
ClimateTechUK· 2022
Ventive
Ventive
Active
IndustrialsUK· 2022
Cetromed
Active
BiotechUK· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns EpiBone?

EpiBone is currently owned by EMV Capital, through EMV Capital Evergreen Fund, since 2020.

When did EMV Capital acquire EpiBone?

EMV Capital acquired EpiBone in 2020.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue